However, two clinical trials did not reach statistical significance in terms of efficacy in preventing new DUs, although there are case reports that have demonstrated its efficacy, even in some of the patients included in the DUAL-2 trial [ 18 - 20 ].
← all excerpts
Macitentan for the Treatment of Refractory Digital Ulcers in Patients With Connective Tissue Diseases.
1
—
—